Oncolytic viruses could be used to 'warm up' cold tumors and improve immunotherapy

Equipping cancer-infecting, or oncolytic, viruses with tumor-inhibiting genetic cargo stimulates the immune system and helps immunotherapy to shrink or completely clear aggressive tumors in mice, according to a new study in the Journal of Experimental Medicine led by University of Pittsburgh and UPMC researchers.

Related Keywords

United States ,American ,Lukasz Wieteska ,Tianhong Yao ,Lily Ramsey ,Mclane Watson ,Kristin Depeaux ,Cynthia Hinck ,Andrew Hinck ,William Gunn ,Dayana Rivadeneira ,Stephen Thorne ,Kalivir Immunotherapeutics ,Konstantinos Lontos ,Greg Delgoffe ,Hillman Cancer Center ,Sy Holzer Endowed Immunotherapy Fund ,University Of Texas ,Alliance For Cancer Gene Therapy ,University Of Pittsburgh ,Neck Cancer Specialized Programs Of Research Excellence ,Van Andel Institute ,Pitt School Of Medicine ,Hillman Cancer Center Skin ,Tumor Microenvironment Center ,National Institutes Of Health ,Hillman Fellows For Innovative Cancer Research Program ,Experimental Medicineled ,Victoria Dean ,Andrew Wilfahrt ,National Institutes ,Cancer Center Skin ,Neck Cancer Specialized Programs ,Research Excellence ,American Association ,Cancer Research Innovative Grant ,Cancer Gene Therapy ,Mark Foundation ,Cancer Research ,Emerging Leader Award ,Cancer Research Institute Lloyd ,Cancer Immunology ,Hillman Fellows ,Innovative Cancer Research ,Cancer ,Gold ,Immunotherapy ,Virus ,Fell ,Cell Line ,Gene ,Enetic ,Immune System ,Mmunology ,Medicine ,Neck ,Mh ,Research ,Humor ,